US5480772A
(en)
|
1993-02-03 |
1996-01-02 |
Brandeis University |
In vitro activation of a nucleus
|
US7307198B2
(en)
|
1995-08-31 |
2007-12-11 |
Roslin Institute |
Ungulates produced by nuclear transfer of G1 cells
|
GB9517779D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
GB9517780D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
US6025155A
(en)
*
|
1996-04-10 |
2000-02-15 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US6077697A
(en)
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US7696404B2
(en)
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
JP2002511732A
(ja)
|
1996-10-11 |
2002-04-16 |
ザ・テキサス・エイ・アンド・エム・ユニヴァーシティ・システム |
トランスジェニック動物を発生させるための組成物および方法
|
US20090092588A1
(en)
*
|
1997-01-10 |
2009-04-09 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
|
US5945577A
(en)
*
|
1997-01-10 |
1999-08-31 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloning using donor nuclei from proliferating somatic cells
|
US6215041B1
(en)
*
|
1997-01-10 |
2001-04-10 |
University Of Mmassachusetts |
Cloning using donor nuclei from a non-quiesecent somatic cells
|
US6235969B1
(en)
*
|
1997-01-10 |
2001-05-22 |
University Of Massachusetts |
Cloning pigs using donor nuclei from non-quiescent differentiated cells
|
GB9703550D0
(en)
*
|
1997-02-20 |
1997-04-09 |
Ppl Therapeutics Scotland Ltd |
Cell mediated transgenesis
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
ATE420157T1
(de)
*
|
1997-04-24 |
2009-01-15 |
Univ Washington |
Zielgerichtete genveraenderung mit parvoviralen vektoren
|
US6921814B2
(en)
|
1997-06-19 |
2005-07-26 |
The General Hospital Corporation |
Torsin, torsin-related genes and methods of detecting neuronal disease
|
EP0989995A2
(fr)
|
1997-06-19 |
2000-04-05 |
The General Hospital Corporation |
Torsine, genes de torsine et leurs utilisations
|
CN101003800A
(zh)
*
|
1997-07-03 |
2007-07-25 |
马萨诸塞大学 |
使用来自无血清饥饿的分化细胞的供体细胞核进行克隆
|
WO1999005266A2
(fr)
*
|
1997-07-26 |
1999-02-04 |
Wisconsin Alumni Research Foundation |
Transfert de noyau entre des especes differentes
|
JP2001513336A
(ja)
*
|
1997-08-22 |
2001-09-04 |
ロスリン インスティチュート(エディンバラ) |
トランスジェニック動物の生産における「マリーナ」トランスポザンの使用
|
AU1581899A
(en)
*
|
1997-10-28 |
1999-05-17 |
Biotransplant Incorporated |
Nuclear transfer for production of transgenic animal embryo
|
WO1999036510A1
(fr)
*
|
1998-01-16 |
1999-07-22 |
Agrobiogen Gmbh |
Transfert de noyau efficace avec des fibroblastes foetaux
|
US6331659B1
(en)
|
1998-01-21 |
2001-12-18 |
University Of Hawaii |
Cumulus cells as nuclear donors
|
EP1067834A4
(fr)
*
|
1998-03-16 |
2002-01-23 |
Garelag Pty Ltd |
Transfert de noyau de cellules porcines
|
AUPP294898A0
(en)
*
|
1998-04-15 |
1998-05-07 |
Monash University |
Method of nuclear transfer
|
GB9808325D0
(en)
*
|
1998-04-20 |
1998-06-17 |
Ltr Ciz Di Associazione Italia |
Source of nuclei for nuclear transfer
|
GB9809178D0
(en)
*
|
1998-04-29 |
1998-07-01 |
Univ Edinburgh |
Nuclear reprogramming of somatic cells
|
AU6218899A
(en)
|
1998-10-12 |
2000-05-01 |
Geron Bio-Med Limited |
Porcine oocytes with improved developmental competence
|
US6781030B1
(en)
|
1998-11-02 |
2004-08-24 |
Trustee Of Tufts College, Ballou Hall |
Methods for cloning mammals using telophase oocytes
|
AU2003204830B2
(en)
*
|
1998-11-02 |
2007-08-30 |
Gtc Biotherapeutics, Inc. |
Transgenic and cloned mammals
|
EP1375654A3
(fr)
*
|
1998-11-02 |
2008-01-16 |
GTC Biotherapeutics, Inc. |
Mammifères trangéniques et clonés
|
CA2350233A1
(fr)
*
|
1998-11-02 |
2000-05-11 |
Genzyme Transgenics Corp. |
Mammiferes transgeniques et clones
|
US6580017B1
(en)
|
1998-11-02 |
2003-06-17 |
Genzyme Transgenics Corporation |
Methods of reconstructed goat embryo transfer
|
WO2000030436A1
(fr)
|
1998-11-19 |
2000-06-02 |
Ppl Therapeutics (Scotland) Ltd. |
Stabilisation du lait provenant d'animaux transgeniques
|
US6700037B2
(en)
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
ATE407203T1
(de)
*
|
1999-01-13 |
2008-09-15 |
Revivicor Inc |
Doppelkerntransfersverfahren und dessen ergebnisse
|
GB9903805D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-1
|
GB9903804D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-2
|
AU3382800A
(en)
|
1999-02-26 |
2000-09-14 |
Millennium Pharmaceuticals, Inc. |
Secreted proteins and uses thereof
|
NZ514620A
(en)
|
1999-03-04 |
2004-04-30 |
Ppl Therapeutics Scotland Ltd |
Genetic modification of somatic cells and uses thereof
|
US20020012660A1
(en)
*
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
WO2000065035A1
(fr)
*
|
1999-04-28 |
2000-11-02 |
Universite De Montreal |
Ovocytes en telophase enuclees pour transfert de noyaux
|
IL146829A0
(en)
*
|
1999-06-04 |
2002-07-25 |
Istituto Zootecnico E Caseario |
Process for reconstructing a non-human animal embryo by nuclear transfer and preparing the animal therefrom, and embryos and animal obtained thereby
|
WO2001000855A1
(fr)
|
1999-06-23 |
2001-01-04 |
Ppl Therapeutics (Scotland) Ltd. |
Proteines de fusion incorporant un lysozyme
|
EP1109890A4
(fr)
*
|
1999-06-30 |
2004-12-29 |
Hwang Woo Suk |
Procede d'obtention d'embryons humains clones au moyen de techniques de transplantation inter-especes de noyaux
|
US6590139B1
(en)
|
1999-06-30 |
2003-07-08 |
Woo-Suk Hwang |
Method for producing cloned cows
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
AU782286B2
(en)
|
1999-06-30 |
2005-07-14 |
Advanced Cell Technology, Inc. |
Cytoplasmic transfer to de-differentiate recipient cells
|
AU753209B2
(en)
*
|
1999-06-30 |
2002-10-10 |
Seoul National University Industry Foundation |
Method for producing cloned tigers by employing inter-species nuclear transplantation technique
|
JP4896327B2
(ja)
|
1999-08-23 |
2012-03-14 |
ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド |
Pd−1、b7−4の受容体、およびその使用
|
WO2002064799A2
(fr)
|
1999-09-28 |
2002-08-22 |
Transkaryotic Therapies, Inc. |
Arn messager optimise
|
EP2275559A3
(fr)
|
1999-09-28 |
2011-03-23 |
Shire Human Genetic Therapies, Inc. |
ARN messager (ARN-m) optimisé
|
KR20020038776A
(ko)
*
|
1999-09-30 |
2002-05-23 |
추후보정 |
클로닝된 트랜스게닉 포유동물의 제조 방법
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US7074983B2
(en)
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
KR100417566B1
(ko)
*
|
1999-11-19 |
2004-02-05 |
한국생명공학연구원 |
체세포 핵치환 복제수정란의 대량생산방법
|
AU1777301A
(en)
*
|
1999-11-19 |
2001-05-30 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
US6635802B1
(en)
*
|
2000-01-10 |
2003-10-21 |
The Texas A&M University System |
Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
|
GB0001401D0
(en)
*
|
2000-01-22 |
2000-03-08 |
Univ Edinburgh |
Methods for amplifying genetic material and use thereof
|
CA2403344C
(fr)
|
2000-03-15 |
2013-05-21 |
The University Of Georgia Research Foundation, Inc. |
Reprogrammation effective de materiel nucleaire chez des mammiferes
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
GB2360522A
(en)
|
2000-03-24 |
2001-09-26 |
Geron Corp |
A strategy for maintaining pregnancy
|
AU2001261650A1
(en)
*
|
2000-05-15 |
2001-11-26 |
Geron Corporation |
Ovine tissue for xenotransplantation
|
AU2001273096B8
(en)
|
2000-06-28 |
2005-10-13 |
Dana-Farber Cancer Institute, Inc. |
PD-L2 molecules: novel PD-1 ligands and uses therefor
|
WO2002009510A2
(fr)
*
|
2000-08-01 |
2002-02-07 |
Xy Genetics, Llc |
Procedes de selection et de clonage
|
IL154751A0
(en)
|
2000-08-03 |
2003-10-31 |
|
Humanized antibodies, recombination vectors, transgenic vectors and methods for the preparation of humanized antibodies from transgenic animals
|
AU2001284948A1
(en)
|
2000-08-15 |
2002-02-25 |
Board Of Trustees Of The University Of Illinois |
Animals expressing exogenous igf-i in their milk
|
AU2001291558A1
(en)
*
|
2000-09-06 |
2002-03-22 |
Nexia Biotechnologies, Inc. |
Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
|
FR2814642B1
(fr)
|
2000-10-03 |
2005-07-01 |
Ass Pour Le Dev De La Rech En |
Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
|
US8105825B2
(en)
*
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
US20040029825A1
(en)
*
|
2001-10-03 |
2004-02-12 |
Davies Christopher J |
Methods of minimizing immunological rejection of a nuclear transfer fetus
|
BR0115715A
(pt)
|
2000-11-28 |
2004-02-03 |
Wyeth Corp |
Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
|
EP1343912A2
(fr)
|
2000-11-28 |
2003-09-17 |
Wyeth |
Analyse d'expression d'acides nucleiques kiaa et polypeptides utilises dans le diagnostic et le traitement du cancer de la prostate
|
EP1217071B1
(fr)
|
2000-12-22 |
2010-04-28 |
Institut National De La Recherche Agronomique |
Expression position-indépendante et tissus-spécifique d' un transgène dans le lait d'animaux transgéniques
|
DE60144248D1
(de)
*
|
2000-12-22 |
2011-04-28 |
Kyowa Hakko Kirin Co Ltd |
Verfahren zur klonierung von nichtmenschliche säugern unter verwendung von reprogrammiertem donorchromatin oder donorzellen
|
US20020142397A1
(en)
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
US7491534B2
(en)
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
EP1860199B1
(fr)
|
2001-01-12 |
2014-03-05 |
Exelixis, Inc. |
Modulation de signal de récépteur d'insuline
|
US20050177883A1
(en)
|
2001-01-30 |
2005-08-11 |
Rebholtz Paul C. |
Systems of transferring embryos and managing recipients
|
AU2002250020A1
(en)
*
|
2001-02-02 |
2002-08-19 |
Erik Forsberg |
Method of cloning transgenic mammalian animals using pseudonuclei
|
ES2424812T3
(es)
*
|
2001-02-20 |
2013-10-08 |
Intrexon Corporation |
Receptores X retinoides quiméricos y su uso en un sistema inducible de expresión génica basado en receptores de ecdisona novedoso
|
JP2004524843A
(ja)
|
2001-02-23 |
2004-08-19 |
イーラン ファーマスーティカルズ、インコーポレイテッド |
Bace−1のトランスジェニックノックアウト
|
JP2002262716A
(ja)
*
|
2001-03-07 |
2002-09-17 |
National Agricultural Research Organization |
株化細胞を用いて家畜個体を作出する方法
|
AU2002258477A1
(en)
*
|
2001-03-08 |
2002-09-24 |
Advanced Cell Technology, Inc. |
Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
|
AUPR363701A0
(en)
|
2001-03-09 |
2001-04-05 |
Garelag Pty Ltd |
Method for the production of nuclear transfer embryos
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
AU2002242854A1
(en)
*
|
2001-03-21 |
2002-10-03 |
Geron Corporation |
Use of telomerase reverse transcriptase to create homozygous knockout animals
|
US7126039B2
(en)
*
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
US20030027330A1
(en)
*
|
2001-04-02 |
2003-02-06 |
Robert Lanza |
Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
|
MXPA03008959A
(es)
|
2001-04-02 |
2004-10-15 |
Wyeth Corp |
Pd-1, un receptor para b7-4 y sus usos.
|
CN1636062A
(zh)
|
2001-04-16 |
2005-07-06 |
惠氏控股公司 |
编码多肽抗原的新肺炎链球菌可读框及其应用
|
WO2002092791A1
(fr)
*
|
2001-05-14 |
2002-11-21 |
Stell |
Tissus ou organes utilises dans la xenotransplantation
|
US20030153044A1
(en)
*
|
2001-05-14 |
2003-08-14 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
AU2002326353A1
(en)
*
|
2001-07-09 |
2003-01-29 |
Alexion Pharmaceuticals Inc. |
Cloned non-human mammals from contact inhibited donor cells
|
EP1900815B1
(fr)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
Production in vivo de petits ARN interférents qui modèrent le silençage génique
|
ES2606290T3
(es)
|
2001-07-12 |
2017-03-23 |
University Of Massachusetts |
Producción in vivo de ARN de interferencia pequeños que median el silenciamiento génico
|
WO2003011016A2
(fr)
*
|
2001-07-31 |
2003-02-13 |
Stell |
Vaches genetiquement modifiees presentant une vulnerabilite reduite a la maladie de la vache folle
|
US20030211603A1
(en)
*
|
2001-08-14 |
2003-11-13 |
Earp David J. |
Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
|
WO2003042362A2
(fr)
|
2001-11-09 |
2003-05-22 |
Dana-Farber Cancer Institute, Inc. |
Pgc-1$g(b), un nouvel homologue du pgc-1 et leurs utilisations
|
US20030134422A1
(en)
*
|
2002-01-16 |
2003-07-17 |
Sayre Chauncey Bigelow |
Stem cell maturation for all tissue lines
|
US20050090004A1
(en)
*
|
2003-01-16 |
2005-04-28 |
Sayre Chauncey B. |
Stem cell maturation for all tissue lines
|
US20050170506A1
(en)
*
|
2002-01-16 |
2005-08-04 |
Primegen Biotech Llc |
Therapeutic reprogramming, hybrid stem cells and maturation
|
JP4968498B2
(ja)
|
2002-01-23 |
2012-07-04 |
ユニバーシティ オブ ユタ リサーチ ファウンデーション |
ジンクフィンガーヌクレアーゼを用いる、標的化された染色体変異誘発
|
KR100502695B1
(ko)
*
|
2002-02-28 |
2005-07-25 |
한국생명공학연구원 |
형질전환 효율이 향상된 복제수정란의 대량 생산 방법
|
ATE531796T1
(de)
*
|
2002-03-21 |
2011-11-15 |
Sangamo Biosciences Inc |
Verfahren und zusammensetzungen zur verwendung von zinkfinger-endonukleasen zur verbesserung der homologen rekombination
|
GB0207299D0
(en)
*
|
2002-03-28 |
2002-05-08 |
Franks Christopher R |
Stem cell therapy
|
CN1650003A
(zh)
*
|
2002-04-01 |
2005-08-03 |
Gtc生物治疗学公司 |
选择用于哺乳动物种中核转移的细胞系的方法
|
US20030207448A1
(en)
*
|
2002-05-06 |
2003-11-06 |
Revera Gregory Henry |
Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo
|
GB0211904D0
(en)
*
|
2002-05-23 |
2002-07-03 |
Medical Res Council |
Nuclear transfer
|
WO2003104423A2
(fr)
*
|
2002-06-11 |
2003-12-18 |
Roy Ogle |
Cellules souches d'origine meningee
|
US7612250B2
(en)
|
2002-07-29 |
2009-11-03 |
Trustees Of Tufts College |
Nuclear transfer embryo formation method
|
AU2003265556A1
(en)
|
2002-08-20 |
2004-03-11 |
Millenium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
|
EP2806025B1
(fr)
|
2002-09-05 |
2019-04-03 |
California Institute of Technology |
Utilisation de nucléases à doigt de zinc pour stimuler le ciblage de gènes
|
AU2003300027A1
(en)
|
2002-10-10 |
2004-05-04 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
US20040077077A1
(en)
*
|
2002-10-18 |
2004-04-22 |
Xiangzhong Yang |
Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same
|
CA2503491A1
(fr)
|
2002-10-24 |
2004-05-06 |
Wyeth |
Compositions, organismes et procedes faisant appel a une nouvelle proteine phosphatase humaine
|
EP1563084A4
(fr)
|
2002-11-08 |
2006-03-01 |
Hematech Llc |
Ongules transgeniques presentant une activite de la proteine prion reduite et leurs utilisations
|
JP2006514554A
(ja)
|
2002-11-21 |
2006-05-11 |
ワイス |
腎細胞癌および他の固形腫瘍の診断法
|
WO2004050831A2
(fr)
|
2002-11-27 |
2004-06-17 |
Wyeth |
Compositions, organismes et procedes faisant appel a une nouvelle kinase humaine
|
WO2004053090A2
(fr)
*
|
2002-12-10 |
2004-06-24 |
Gtc Biotherapeutics, Inc. |
Procede et systeme d'utilisation d'embryons de transfert nucleaire cellulaire de cellule somatique en tant que donneurs de cellules pour un transfert nucleaire supplementaire
|
AU2003299818A1
(en)
|
2002-12-20 |
2004-07-22 |
Applera Corporation |
Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
AU2004203749A1
(en)
|
2003-01-06 |
2004-07-22 |
Wyeth |
Compositions and methods for diagnosing and treating colon cancers
|
FR2855183B1
(fr)
|
2003-05-23 |
2005-08-12 |
Agronomique Inst Nat Rech |
Procede de clonage du rat par transfert nucleaire
|
DK1633767T3
(en)
|
2003-06-02 |
2019-03-25 |
Univ Massachusetts |
METHODS AND COMPOSITIONS FOR MANAGING THE EFFECT OF RNA SILENCING
|
EP2314692B1
(fr)
|
2003-06-02 |
2021-02-24 |
University of Massachusetts |
Procédés et compositions permettant d'améliorer l'efficacité et la spécificité d'ARNi
|
US7888121B2
(en)
*
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US20080050313A1
(en)
|
2003-08-14 |
2008-02-28 |
Exelixis, Inc. |
Sulfs as Modifiers of the Beta-Catenin Pathway and Methods of Use
|
EP2261667A3
(fr)
|
2003-10-07 |
2011-05-25 |
Millennium Pharmaceuticals, Inc. |
Molécules d'acide nucléique et protéines pour l'identification, évaluation, prévention, et thérapie du cancer de l'ovaire
|
WO2005046450A2
(fr)
|
2003-11-12 |
2005-05-26 |
Children's Hospital Medical Center |
Procede de diagnostic et de traitement de troubles pulmonaires
|
WO2005056837A2
(fr)
|
2003-11-26 |
2005-06-23 |
Applera Corporation |
Polymorphismes genetiques associes a des troubles cardiovasculaires et a une reponse au medicament, leurs procedes de detection et d'utilisation
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
EP1749102A4
(fr)
|
2004-04-22 |
2009-02-25 |
Kirin Pharma Kk |
Animaux transgeniques et leurs utilisations
|
US7820380B2
(en)
|
2004-05-07 |
2010-10-26 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis
|
JP2006081542A
(ja)
*
|
2004-08-18 |
2006-03-30 |
Institute Of Physical & Chemical Research |
クローン哺乳動物の作成方法
|
CA2584331A1
(fr)
|
2004-10-22 |
2006-05-04 |
Dana-Farber Cancer Institute, Inc. |
Compositions et methodes destinees a moduler pgc-1.beta. pour traiter les maladies et les troubles lipidiques
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
CN1274829C
(zh)
|
2004-12-10 |
2006-09-13 |
四川大学华西医院 |
抗eb病毒所致肿瘤多肽及其应用与制备方法
|
JP5590697B2
(ja)
|
2005-03-11 |
2014-09-17 |
セレラ コーポレーション |
冠動脈心疾患に関連する遺伝的多型、その検出方法および使用
|
US20060286666A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Kang Ji Y |
Methods and apparatuses for culturing stem cell using biomaterial shell
|
EP1924697A2
(fr)
*
|
2005-06-29 |
2008-05-28 |
Cameron Clokie |
Production de protéines morphogéniques osseuses dans des mammiféres transgéniques
|
KR100733012B1
(ko)
|
2005-07-26 |
2007-06-28 |
재단법인서울대학교산학협력재단 |
복제된 개과 동물 및 이의 생산 방법
|
CA2909775A1
(fr)
|
2005-08-09 |
2007-03-29 |
Revivicor, Inc. |
Ongules transgeniques exprimant la ctla4-ig et leurs utilisations
|
AU2006287315B2
(en)
|
2005-09-09 |
2013-02-21 |
The Johns Hopkins University |
Manipulation of regulatory T cell and DC function by targeting neuritin gene using antibodies, agonists and antagonists
|
CA2623106C
(fr)
|
2005-09-19 |
2013-12-24 |
Histogenics Corporation |
Matrice support de cellules dont la densite des pores et la porosite sont definies specifiquement de maniere uniforme verticalement et organisees de maniere non aleatoire, et procede de preparation de celle-ci
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
US7695911B2
(en)
|
2005-10-26 |
2010-04-13 |
Celera Corporation |
Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
|
WO2007124019A2
(fr)
|
2006-04-21 |
2007-11-01 |
Gtc Biotherapeutics, Inc. |
Procédés et produits relatifs au transfert de molécules du sang à la glande mammaire
|
PE20081216A1
(es)
|
2006-09-01 |
2008-09-04 |
Therapeutic Human Polyclonals Inc |
Expresion mejorada de la inmunoglobulina humana o humanizada en animales transgenicos no humanos
|
US7993833B2
(en)
|
2006-09-11 |
2011-08-09 |
Celera Corporation |
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
WO2008051511A2
(fr)
|
2006-10-20 |
2008-05-02 |
Applera Corporation |
Polymorphismes génétiques associés à la thrombose veineuse, procédés pour les détecter et utilisations
|
KR101398220B1
(ko)
*
|
2006-10-30 |
2014-05-22 |
건국대학교 산학협력단 |
형질전환 배아 생성방법
|
WO2008085891A1
(fr)
*
|
2007-01-05 |
2008-07-17 |
Worcester Polytechnic Institute |
Amélioration du clonage de cellules somatiques grâce à des facteurs associés au fuseau des ovocytes
|
KR100829426B1
(ko)
|
2007-01-17 |
2008-05-15 |
재단법인서울대학교산학협력재단 |
복제개의 생산 방법
|
US20080222745A1
(en)
*
|
2007-03-07 |
2008-09-11 |
Utah State University |
Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning
|
KR100868245B1
(ko)
|
2007-05-29 |
2008-11-11 |
강원대학교산학협력단 |
데메콜친 처리에 의한 효율적인 복제 동물의 생산방법
|
WO2009055656A2
(fr)
|
2007-10-26 |
2009-04-30 |
Centocor, Inc. |
Vecteurs, cellules hôtes, procédés de production et utilisations
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
EP2232985A4
(fr)
|
2008-01-04 |
2011-02-16 |
Seoul Nat Univ Ind Foundation |
Procédé de production de canidés transgéniques clonés
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
JP5670755B2
(ja)
|
2008-03-12 |
2015-02-18 |
ザ ロックフェラー ユニバーシティ |
翻訳プロファイリング及び分子表現型解析のための方法及び組成物
|
US8288094B2
(en)
|
2008-04-09 |
2012-10-16 |
Institut Pasteur |
APOBEC3 mediated DNA editing
|
EP3225252A1
(fr)
|
2008-05-02 |
2017-10-04 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Traitement de saignement par un fibrinogène de faible demi-vie
|
JP5688970B2
(ja)
*
|
2008-07-07 |
2015-03-25 |
タカラバイオ株式会社 |
多能性幹細胞の製造方法
|
WO2010006215A1
(fr)
|
2008-07-09 |
2010-01-14 |
Celera Corporation |
Polymorphismes génétiques associés à des maladies cardiovasculaires et procédés de détection et d'utilisation de ceux-ci
|
US9181315B2
(en)
|
2009-01-08 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
EP2421980A2
(fr)
|
2009-04-23 |
2012-02-29 |
Transposagen Biopharmaceuticals, Inc. |
Rats génétiquement modifiés comme modèles de cancer
|
EP2267153A1
(fr)
|
2009-05-26 |
2010-12-29 |
Université Claude Bernard Lyon 1 |
Identification de la mutation du gène unc5c du récepteur de la nétrine-1 dans des cancers solides
|
EP2449112A1
(fr)
|
2009-07-01 |
2012-05-09 |
Transposagen Biopharmaceuticals, Inc. |
Modèles de rats génétiquement modifiés pour l'immunodéficience combinée sévère
|
US8558055B2
(en)
|
2009-07-24 |
2013-10-15 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease
|
WO2011014721A2
(fr)
|
2009-07-30 |
2011-02-03 |
Transposagen Biopharmaceuticals, Inc. |
Modèles de rat génétiquement modifiés pour pharmacocinétique
|
EP2461672A2
(fr)
|
2009-08-05 |
2012-06-13 |
Transposagen Biopharmaceuticals, Inc. |
Modèles de rats génétiquement modifiés pour le métabolisme de médicaments
|
EP2467013A2
(fr)
|
2009-08-20 |
2012-06-27 |
Transposagen Biopharmaceuticals, Inc. |
Modèles de rat génétiquement modifié pour l'analyse de la douleur
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
CA2787685A1
(fr)
|
2010-01-22 |
2011-07-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, et procedes d'identification, d'evaluation, de prevention, et de therapie de troubles metaboliques
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
JP6034283B2
(ja)
|
2010-03-26 |
2016-11-30 |
トラスティーズ・オブ・ダートマス・カレッジ |
Vista制御性t細胞メディエータタンパク質、vista結合剤、およびその使用
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
ES2738476T3
(es)
|
2010-08-11 |
2020-01-23 |
Inst Nat Sante Rech Med |
Cocultivos de células del cúmulo y embriones durante procedimientos de fertilización in vitro
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
US8748178B2
(en)
|
2010-11-23 |
2014-06-10 |
The New York Stem Cell Foundation |
Method for producing pluripotent stem cells
|
CN104774871A
(zh)
|
2011-02-14 |
2015-07-15 |
雷维维科公司 |
用于血管化异种移植物及其衍生物的异种移植的遗传修饰的猪
|
WO2012129198A1
(fr)
|
2011-03-23 |
2012-09-27 |
Transposagen Biopharmaceuticals, Inc. |
Modèles de rat génétiquement modifiés pour l'étude de l'obésité et du diabète
|
PT2709445T
(pt)
|
2011-05-16 |
2018-11-27 |
Univ Missouri |
Animais resistentes ao vírus da síntese reprodutiva e respiratória porcino
|
WO2013039996A1
(fr)
|
2011-09-13 |
2013-03-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions et procédés pour induction et activité de tissu adipeux brun à l'aide de fndc5
|
CN102391989A
(zh)
*
|
2011-10-12 |
2012-03-28 |
扬州大学 |
转基因动物重组产物精确分析检验方法
|
TWI605061B
(zh)
|
2012-02-15 |
2017-11-11 |
諾佛 儂迪克股份有限公司 |
會結合及阻斷表現在骨髓細胞上觸發受體-1(trem-1)之抗體
|
JP6400480B2
(ja)
|
2012-02-15 |
2018-10-03 |
ノヴォ ノルディスク アー/エス |
ペプチドグリカン認識タンパク質1に結合する抗体
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
CA2877533C
(fr)
|
2012-06-22 |
2022-08-16 |
The Trustees Of Dartmouth College |
Nouveaux produits de recombinaison vista-ig et leur utilisation dans le traitement des troubles autoimmuns, allergiques et inflammatoires
|
CN105246507B
(zh)
|
2012-09-07 |
2019-01-25 |
达特茅斯大学理事会 |
用于诊断和治疗癌症的vista调节剂
|
US20140115728A1
(en)
|
2012-10-24 |
2014-04-24 |
A. Joseph Tector |
Double knockout (gt/cmah-ko) pigs, organs and tissues
|
WO2014140927A2
(fr)
|
2013-02-13 |
2014-09-18 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Protéines à glycosylation modifiée et leurs procédés de production
|
AR094780A1
(es)
|
2013-02-13 |
2015-08-26 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
ANTICUERPOS ANTI-TNF-a ALTAMENTE GALACTOSILADOS Y SUS USOS
|
US20160102319A1
(en)
|
2013-04-30 |
2016-04-14 |
Konkuk University Industrial Cooperation Corp. |
Cmp-acetylneuraminic acid hydroxylase targeting vector, transgenic animal for xenotransplantation introduced with the vector, and method of manufacturing the same
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
CA3190821A1
(fr)
|
2013-12-24 |
2015-07-02 |
Janssen Pharmaceutica Nv |
Anticorps et fragments anti-vista
|
EP3154585B1
(fr)
|
2014-06-11 |
2022-02-23 |
Kathy A. Green |
Utilisation d'antagonistes et d'agonistes vista pour supprimer ou améliorer l'immunité humorale
|
KR102641268B1
(ko)
|
2014-07-17 |
2024-02-27 |
노보 노르디스크 에이/에스 |
점도를 감소시키기 위한 trem-1 항체의 부위 지정 돌연변이유발
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|
JP2018505911A
(ja)
|
2014-12-05 |
2018-03-01 |
イミュネクスト,インコーポレーテッド |
推定上のvista受容体としてのvsig8の同定と、vista/vsig8調節剤を産生するためのその使用
|
IL282649B
(en)
|
2014-12-09 |
2022-07-01 |
Regeneron Pharma |
Non-human animals with a humanized gene for differentiation cluster 274
|
CN104823921A
(zh)
*
|
2015-05-21 |
2015-08-12 |
蒙汉勤 |
一种用于人体烧伤皮肤移植及医学实验的小型香猪的饲养技术
|
WO2016207717A1
(fr)
|
2015-06-24 |
2016-12-29 |
Janssen Pharmaceutica Nv |
Anticorps et fragments anti-vista
|
JP2018525000A
(ja)
|
2015-08-06 |
2018-09-06 |
ザ・キュレーターズ・オブ・ザ・ユニバーシティ・オブ・ミズーリThe Curators Of The University Of Missouri |
改変cd163遺伝子を有する病原体抵抗性動物
|
WO2017075329A2
(fr)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Procédés pour identifier, évaluer, prévenir et traiter des troubles métaboliques au moyen de pm20d1 et d'acides aminés n-lipidés
|
WO2017137830A1
(fr)
|
2016-02-12 |
2017-08-17 |
Janssen Pharmaceutica Nv |
Anticorps anti-vista (b7h5)
|
UA125382C2
(uk)
|
2016-04-15 |
2022-03-02 |
Імьюнекст Інк. |
Антитіла проти людського vista та їх застосування
|
KR20200139219A
(ko)
|
2018-04-02 |
2020-12-11 |
브리스톨-마이어스 스큅 컴퍼니 |
항-trem-1 항체 및 이의 용도
|
CN112272516B
(zh)
|
2018-04-06 |
2023-05-30 |
儿童医疗中心有限公司 |
用于体细胞重新编程和调整印记的组合物和方法
|
US11160260B2
(en)
|
2018-04-17 |
2021-11-02 |
The Curators Of The University Of Missouri |
Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
|
US11548938B2
(en)
|
2018-08-21 |
2023-01-10 |
Quidel Corporation |
DbpA antibodies and uses thereof
|
CN115298213A
(zh)
|
2019-12-19 |
2022-11-04 |
奎多公司 |
单克隆抗体融合
|
AU2021385081A1
(en)
|
2020-11-20 |
2023-06-29 |
Revivicor, Inc. |
Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantation
|
WO2023044100A1
(fr)
|
2021-09-20 |
2023-03-23 |
Revivicor, Inc. |
Porcs scéniques multitran comprenant dix modifications génétiques pour une xénogreffe
|